30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Tetraphase Pharmaceuticals Inc (TTPH)

Track

Stock chart
Ticker: TTPH Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
LA JOLLA PHARMACEUTICAL CO
1 purchase — total 7,474,720 USD
Buy 28 Jul 2020
Value US$553,418.71 | Price 196.20 | Shares 59,842
Buy 19 Jun 2020
Value US$2,803,487.05 | Price 167.10 | Shares 77,564
Sale 10 Dec 2019
Value US$1,147.56 | Price 2.19 | Shares 524
Sale 10 Dec 2019
Value US$31,770.33 | Price 2.19 | Shares 14,507
Sale 6 Dec 2019
Value US$12,902.96 | Price 2.25 | Shares 5,735
Sale 5 Dec 2019
Value US$4,376.62 | Price 2.34 | Shares 1,870
Planned sale 8 Jan 2019
Value US$11,995.20 | Price 1.60 | Shares 7,497
Planned sale 30 Jan 2018
Value US$54,425.00 | Price 6.22 | Shares 8,750
Planned sale 9 Jan 2018
Value US$44,507.07 | Price 6.21 | Shares 7,167
Buy 29 Nov 2017
Value US$25,026.00 | Price 6.45 | Shares 3,880
Planned sale 31 Oct 2017
Value US$52,762.50 | Price 6.03 | Shares 8,750
Planned sale 22 Aug 2017
Value US$105,000.00 | Price 6.00 | Shares 17,500
Planned sale 17 Aug 2017
Value US$41,928.30 | Price 5.86 | Shares 7,155
Buy 15 Mar 2017
Value US$7,470.00 | Price 7.47 | Shares 1,000
Buy 15 Mar 2017
Value US$74,900.00 | Price 7.49 | Shares 10,000
Planned sale 8 Sep 2015
Value US$440,800.00 | Price 44.08 | Shares 10,000
Planned sale 1 Sep 2015
Value US$415,700.00 | Price 41.57 | Shares 10,000
Planned sale 14 Aug 2015
Value US$407,740.00 | Price 42.92 | Shares 9,500
Planned sale 13 Aug 2015
Value US$446,900.00 | Price 44.69 | Shares 10,000
Sale 12 Aug 2015
Value US$675,000.00 | Price 45.00 | Shares 15,000
Planned sale 5 Aug 2015
Value US$463,100.00 | Price 46.31 | Shares 10,000
Planned sale 3 Aug 2015
Value US$474,500.00 | Price 47.45 | Shares 10,000
Planned sale 14 Jul 2015
Value US$366,900.00 | Price 48.92 | Shares 7,500
Planned sale 13 Jul 2015
Value US$489,300.00 | Price 48.93 | Shares 10,000
Planned sale 6 Jul 2015
Value US$479,100.00 | Price 47.91 | Shares 10,000
Planned sale 1 Jul 2015
Value US$479,200.00 | Price 47.92 | Shares 10,000
Planned sale 15 Jun 2015
Value US$415,100.00 | Price 41.51 | Shares 10,000
Planned sale 15 Jun 2015
Value US$312,525.00 | Price 41.67 | Shares 7,500
Planned sale 12 Jun 2015
Value US$417,200.00 | Price 41.72 | Shares 10,000
Sale 12 Jun 2015
Value US$412,900.00 | Price 41.29 | Shares 10,000
Sale 8 Jun 2015
Value US$457,391.00 | Price 43.00 | Shares 10,637
Sale 8 Jun 2015
Value US$515,997.00 | Price 43.50 | Shares 11,862
Sale 1 Jun 2015
Value US$209,600.00 | Price 41.92 | Shares 5,000
Sale 1 Jun 2015
Value US$45,632.26 | Price 41.98 | Shares 1,087
Planned sale 1 Jun 2015
Value US$418,600.00 | Price 41.86 | Shares 10,000
Planned sale 15 May 2015
Value US$1,188,900.00 | Price 39.63 | Shares 30,000
Planned sale 14 May 2015
Value US$287,372.48 | Price 39.28 | Shares 7,316
Planned sale 14 May 2015
Value US$301,827.52 | Price 39.28 | Shares 7,684
Planned sale 13 May 2015
Value US$398,800.00 | Price 39.88 | Shares 10,000
Planned sale 11 May 2015
Value US$830,200.00 | Price 41.51 | Shares 20,000
Planned sale 2 Mar 2015
Value US$388,766.00 | Price 39.67 | Shares 9,800
Planned sale 2 Mar 2015
Value US$7,780.00 | Price 38.90 | Shares 200
Planned sale 2 Feb 2015
Value US$266,684.00 | Price 35.09 | Shares 7,600
Planned sale 2 Feb 2015
Value US$86,232.00 | Price 35.93 | Shares 2,400
Planned sale 20 Jan 2015
Value US$1,248,972.34 | Price 36.59 | Shares 34,135
Planned sale 2 Oct 2014
Value US$1,636,799.39 | Price 21.02 | Shares 77,862
Planned sale 2 Oct 2014
Value US$574,346.86 | Price 20.72 | Shares 27,726
Planned sale 1 Oct 2014
Value US$2,668,843.88 | Price 20.89 | Shares 127,746
Planned sale 30 Sep 2014
Value US$1,141,843.52 | Price 20.17 | Shares 56,618
Planned sale 23 Sep 2014
Value US$184,660.00 | Price 18.47 | Shares 10,000
Planned sale 17 Sep 2014
Value US$180,000.00 | Price 18.00 | Shares 10,000
Planned sale 17 Sep 2014
Value US$1,336,596.80 | Price 17.36 | Shares 77,000
Planned sale 12 Sep 2014
Value US$910,756.67 | Price 17.01 | Shares 53,544
Planned sale 8 Sep 2014
Value US$67,126.31 | Price 15.01 | Shares 4,473
Planned sale 4 Sep 2014
Value US$620,595.60 | Price 15.06 | Shares 41,200
Planned sale 20 Aug 2014
Value US$115,900.00 | Price 11.59 | Shares 10,000
Planned sale 18 Jul 2014
Value US$159,102.00 | Price 10.61 | Shares 15,000
Planned sale 20 Jun 2014
Value US$1,128,932.78 | Price 13.65 | Shares 82,716
Planned sale 17 Jun 2014
Value US$184,225.50 | Price 12.28 | Shares 15,000
Buy 13 Jun 2014
Value US$5,710.00 | Price 11.42 | Shares 500
Buy 5 Jun 2014
Value US$10,026.90 | Price 10.28 | Shares 975
Buy 4 Jun 2014
Value US$5,025.00 | Price 10.05 | Shares 500
Buy 28 May 2014
Value US$9,095.00 | Price 10.70 | Shares 850
Planned sale 19 May 2014
Value US$135,000.00 | Price 9.00 | Shares 15,000
Buy 19 May 2014
Value US$230,977.50 | Price 9.24 | Shares 25,000
Buy 14 May 2014
Value US$46,249.00 | Price 9.25 | Shares 5,000
Planned sale 14 Apr 2014
Value US$145,350.00 | Price 9.69 | Shares 15,000
Planned sale 10 Feb 2014
Value US$216,300.00 | Price 14.42 | Shares 15,000
Sale 7 Feb 2014
Value US$141,176.16 | Price 14.22 | Shares 9,928
Sale 5 Feb 2014
Value US$160,111.42 | Price 13.93 | Shares 11,494
Sale 18 Sep 2013
Value US$23,817.00 | Price 10.20 | Shares 2,335
Sale 18 Sep 2013
Value US$996,183.00 | Price 10.20 | Shares 97,665
Sale 17 Sep 2013
Value US$1,820.16 | Price 9.48 | Shares 192
Sale 17 Sep 2013
Value US$75,953.76 | Price 9.48 | Shares 8,012
Sale 16 Sep 2013
Value US$9,745.54 | Price 9.22 | Shares 1,057
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-29 2020-07-28 B Purchase
LA JOLLA PHARMACEUTICAL CO
Large shareholder
59,842 +27.3%
196.20
US$553,419 		59,842 +27.3% 196.20 US$553,419
2020-06-22 2020-06-19 B Purchase
LA JOLLA PHARMACEUTICAL CO
Large shareholder
77,564 -4.2%
167.10
US$2,803,487 		77,564 -4.2% 167.10 US$2,803,487
2019-12-12 2019-12-10 S Sale Freund John Gordon Non-Executive Director
70,505 +47.2%
58.28
US$957,696 		70,505 +47.2% 58.28 US$957,696
2019-12-12 2019-12-10 S Sale Freund John Gordon Non-Executive Director
14,507 -100.0%
2.19
US$31,770 		14,507 -100.0% 2.19 US$31,770
2019-12-09 2019-12-06 S Sale Macdonald Guy Non-Executive Director
5,735 -95.8%
2.25
US$12,903 		5,735 -95.8% 2.25 US$12,903
2019-12-09 2019-12-05 S Sale Macdonald Guy Non-Executive Director
1,870 -23.8%
2.34
US$4,377 		1,870 -23.8% 2.34 US$4,377
2019-01-10 2019-01-08 PlS Planned sale
Dumas Jacques

Chief ScientificOfficer

Officer
7,497 -100.0%
1.60
US$11,995 		7,497 -100.0% 1.60 US$11,995
2018-01-31 2018-01-30 PlS Planned sale Dumas Jacques

Chief ScientificOfficer

Officer
8,750 -100.0%
6.22
US$54,425 		8,750 -100.0% 6.22 US$54,425
2018-01-11 2018-01-09 PlS Planned sale Dumas Jacques

Chief ScientificOfficer

Officer
7,167 -100.0%
6.21
US$44,507 		7,167 -100.0% 6.21 US$44,507
2017-12-04 2017-11-29 B Purchase GAGE L PATRICK
3,880 +11.1%
6.45
US$25,026 		3,880 +11.1% 6.45 US$25,026
2017-11-02 2017-10-31 PlS Planned sale Dumas Jacques

Chief ScientificOfficer
8,750 -100.0%
6.03
US$52,762 		8,750 -100.0% 6.03 US$52,762
2017-08-24 2017-08-22 PlS Planned sale Dumas Jacques

Chief ScientificOfficer
17,500 -100.0%
6.00
US$105,000 		17,500 -100.0% 6.00 US$105,000
2017-08-21 2017-08-17 PlS Planned sale Dumas Jacques

Chief ScientificOfficer
7,155 -100.0%
5.86
US$41,928 		7,155 -100.0% 5.86 US$41,928
2017-03-16 2017-03-15 B Purchase GAGE L PATRICK Non-Executive Director
1,000 +35.4%
7.47
US$7,470 		1,000 +35.4% 7.47 US$7,470
2017-03-16 2017-03-15 B Purchase GAGE L PATRICK Non-Executive Director
10,000 +40.0%
7.49
US$74,900 		10,000 +40.0% 7.49 US$74,900
2015-09-10 2015-09-08 PlS Planned sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
10,000 -96.7%
44.08
US$440,800 		10,000 -96.7% 44.08 US$440,800
2015-09-03 2015-09-01 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -16.1%
41.57
US$415,700 		10,000 -16.1% 41.57 US$415,700
2015-08-17 2015-08-14 PlS Planned sale Lubner David Charles

SVP and CFO

Officer
9,500 -12.1%
42.92
US$407,740 		9,500 -12.1% 42.92 US$407,740
2015-08-17 2015-08-13 PlS Planned sale Horn Patrick Taylor

Chief Medical Officer

Officer
10,000 -100.0%
44.69
US$446,900 		10,000 -100.0% 44.69 US$446,900
2015-08-14 2015-08-12 S Sale GAGE L PATRICK Non-Executive Director
15,000 -75.0%
45.00
US$675,000 		15,000 -75.0% 45.00 US$675,000
2015-08-07 2015-08-05 PlS Planned sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
10,000 -96.7%
46.31
US$463,100 		10,000 -96.7% 46.31 US$463,100
2015-08-03 2015-08-03 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -12.5%
47.45
US$474,500 		10,000 -12.5% 47.45 US$474,500
2015-07-15 2015-07-14 PlS Planned sale Lubner David Charles

SVP and CFO

Officer
7,500 -9.8%
48.92
US$366,900 		7,500 -9.8% 48.92 US$366,900
2015-07-15 2015-07-13 PlS Planned sale Horn Patrick Taylor

Chief Medical Officer

Officer
10,000 -100.0%
48.93
US$489,300 		10,000 -100.0% 48.93 US$489,300
2015-07-08 2015-07-06 PlS Planned sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
10,000 -96.7%
47.91
US$479,100 		10,000 -96.7% 47.91 US$479,100
2015-07-02 2015-07-01 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -10.5%
47.92
US$479,200 		10,000 -10.5% 47.92 US$479,200
2015-06-16 2015-06-15 PlS Planned sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
10,000 -96.7%
41.51
US$415,100 		10,000 -96.7% 41.51 US$415,100
2015-06-16 2015-06-15 PlS Planned sale Lubner David Charles

SVP and CFO

Officer
7,500 -9.8%
41.67
US$312,525 		7,500 -9.8% 41.67 US$312,525
2015-06-16 2015-06-12 PlS Planned sale Horn Patrick Taylor

Chief Medical Officer

Officer
10,000 -100.0%
41.72
US$417,200 		10,000 -100.0% 41.72 US$417,200
2015-06-16 2015-06-12 S Sale Lubner David Charles

SVP and CFO

Officer
10,000 -12.6%
41.29
US$412,900 		10,000 -12.6% 41.29 US$412,900
2015-06-10 2015-06-08 S Sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
10,637 -96.9%
43.00
US$457,391 		10,637 -96.9% 43.00 US$457,391
2015-06-10 2015-06-08 S Sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
11,862 -51.9%
43.50
US$515,997 		11,862 -51.9% 43.50 US$515,997
2015-06-03 2015-06-01 S Sale Macdonald Guy

President and Chief Executive

Executive Director
5,000 -5.6%
41.92
US$209,600 		5,000 -5.6% 41.92 US$209,600
2015-06-03 2015-06-01 S Sale Macdonald Guy

President and Chief Executive

Executive Director
1,087 -1.5%
41.98
US$45,632 		1,087 -1.5% 41.98 US$45,632
2015-06-03 2015-06-01 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -12.3%
41.86
US$418,600 		10,000 -12.3% 41.86 US$418,600
2015-05-19 2015-05-15 PlS Planned sale THOMPSON JOHN CRAIG

Chief Operating Officer

Officer
30,000 -98.9%
39.63
US$1,188,900 		30,000 -98.9% 39.63 US$1,188,900
2015-05-18 2015-05-14 PlS Planned sale Lubner David Charles

SVP and CFO

Officer
7,316 -8.4%
39.28
US$287,372 		7,316 -8.4% 39.28 US$287,372
2015-05-18 2015-05-14 PlS Planned sale Lubner David Charles

SVP and CFO

Officer
7,684 -8.8%
39.28
US$301,828 		7,684 -8.8% 39.28 US$301,828
2015-05-15 2015-05-13 PlS Planned sale Horn Patrick Taylor

Chief Medical Officer

Officer
10,000 -100.0%
39.88
US$398,800 		10,000 -100.0% 39.88 US$398,800
2015-05-13 2015-05-11 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
20,000 -22.1%
41.51
US$830,200 		20,000 -22.1% 41.51 US$830,200
2015-03-04 2015-03-02 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
9,800 -16.2%
39.67
US$388,766 		9,800 -16.2% 39.67 US$388,766
2015-03-04 2015-03-02 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
200 -0.3%
38.90
US$7,780 		200 -0.3% 38.90 US$7,780
2015-02-04 2015-02-02 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
7,600 -13.2%
35.09
US$266,684 		7,600 -13.2% 35.09 US$266,684
2015-02-04 2015-02-02 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
2,400 -4.0%
35.93
US$86,232 		2,400 -4.0% 35.93 US$86,232
2015-01-22 2015-01-20 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
34,135 -40.6%
36.59
US$1,248,972 		34,135 -40.6% 36.59 US$1,248,972
2014-10-03 2014-10-02 PlS Planned sale Freund John Gordon Non-Executive Director
77,862 -8.0%
21.02
US$1,636,799 		77,862 -8.0% 21.02 US$1,636,799
2014-10-03 2014-10-02 PlS Planned sale Freund John Gordon Non-Executive Director
27,726 -2.8%
20.72
US$574,347 		27,726 -2.8% 20.72 US$574,347
2014-10-03 2014-10-01 PlS Planned sale Freund John Gordon Non-Executive Director
127,746 -11.4%
20.89
US$2,668,844 		127,746 -11.4% 20.89 US$2,668,844
2014-10-01 2014-09-30 PlS Planned sale Freund John Gordon Non-Executive Director
56,618 -4.7%
20.17
US$1,141,844 		56,618 -4.7% 20.17 US$1,141,844
2014-09-25 2014-09-23 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -16.7%
18.47
US$184,660 		10,000 -16.7% 18.47 US$184,660
2014-09-18 2014-09-17 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -16.7%
18.00
US$180,000 		10,000 -16.7% 18.00 US$180,000
2014-09-18 2014-09-17 PlS Planned sale Freund John Gordon Non-Executive Director
77,000 -5.6%
17.36
US$1,336,597 		77,000 -5.6% 17.36 US$1,336,597
2014-09-15 2014-09-12 PlS Planned sale Freund John Gordon Non-Executive Director
53,544 -3.6%
17.01
US$910,757 		53,544 -3.6% 17.01 US$910,757
2014-09-09 2014-09-08 PlS Planned sale Freund John Gordon Non-Executive Director
4,473 -0.3%
15.01
US$67,126 		4,473 -0.3% 15.01 US$67,126
2014-09-05 2014-09-04 PlS Planned sale Freund John Gordon Non-Executive Director
41,200 -2.7%
15.06
US$620,596 		41,200 -2.7% 15.06 US$620,596
2014-08-22 2014-08-20 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
10,000 -16.7%
11.59
US$115,900 		10,000 -16.7% 11.59 US$115,900
2014-07-22 2014-07-18 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
15,000 -37.5%
10.61
US$159,102 		15,000 -37.5% 10.61 US$159,102
2014-06-23 2014-06-20 PlS Planned sale Freund John Gordon Non-Executive Director
82,716 -4.5%
13.65
US$1,128,933 		82,716 -4.5% 13.65 US$1,128,933
2014-06-19 2014-06-17 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
15,000 -100.0%
12.28
US$184,226 		15,000 -100.0% 12.28 US$184,226
2014-06-17 2014-06-13 B Purchase GAGE L PATRICK Non-Executive Director
500 +21.5%
11.42
US$5,710 		500 +21.5% 11.42 US$5,710
2014-06-09 2014-06-05 B Purchase GAGE L PATRICK Non-Executive Director
975 +72.2%
10.28
US$10,027 		975 +72.2% 10.28 US$10,027
2014-06-05 2014-06-04 B Purchase GAGE L PATRICK Non-Executive Director
500 +58.8%
10.05
US$5,025 		500 +58.8% 10.05 US$5,025
2014-06-03 2014-05-28 B Purchase GAGE L PATRICK Non-Executive Director
850 +inf%
10.70
US$9,095 		850 +inf% 10.70 US$9,095
2014-05-21 2014-05-19 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
15,000 -100.0%
9.00
US$135,000 		15,000 -100.0% 9.00 US$135,000
2014-05-21 2014-05-19 B Purchase Gullans Steven R. Ph.D. Non-Executive Director
25,000 +inf%
9.24
US$230,978 		25,000 +inf% 9.24 US$230,978
2014-05-16 2014-05-14 B Purchase GAGE L PATRICK Non-Executive Director
5,000 +inf%
9.25
US$46,249 		5,000 +inf% 9.25 US$46,249
2014-04-16 2014-04-14 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
15,000 -100.0%
9.69
US$145,350 		15,000 -100.0% 9.69 US$145,350
2014-02-12 2014-02-10 PlS Planned sale Macdonald Guy

President and Chief Executive

Executive Director
15,000 -100.0%
14.42
US$216,300 		15,000 -100.0% 14.42 US$216,300
2014-02-11 2014-02-07 S Sale Lubner David Charles

SVP and CFO

Officer
9,928 -8.9%
14.22
US$141,176 		9,928 -8.9% 14.22 US$141,176
2014-02-07 2014-02-05 S Sale Sutcliffe Joyce A.

Senior Vice President, Biology

Officer
11,494 -22.2%
13.93
US$160,111 		11,494 -22.2% 13.93 US$160,111
2013-09-20 2013-09-18 S Sale CMEA VENTURES VI LP Large shareholder
2,335 -4.6%
10.20
US$23,817 		2,335 -4.6% 10.20 US$23,817
2013-09-20 2013-09-18 S Sale CMEA VENTURES VI LP Large shareholder
97,665 -4.6%
10.20
US$996,183 		97,665 -4.6% 10.20 US$996,183
2013-09-18 2013-09-17 S Sale CMEA VENTURES VI LP Large shareholder
192 -0.4%
9.48
US$1,820 		192 -0.4% 9.48 US$1,820
2013-09-18 2013-09-17 S Sale CMEA VENTURES VI LP Large shareholder
8,012 -0.4%
9.48
US$75,954 		8,012 -0.4% 9.48 US$75,954
2013-09-18 2013-09-16 S Sale CMEA VENTURES VI LP Large shareholder
1,057 -2.0%
9.22
US$9,746 		1,057 -2.0% 9.22 US$9,746
Explore more

More insider trading research around Tetraphase Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America